Literature DB >> 17634686

Malignant mesothelioma: global incidence and relationship with asbestos.

Claudio Bianchi1, Tommaso Bianchi.   

Abstract

Mesothelioma incidence varies markedly from one country to another. The highest annual crude incidence rates (about 30 cases per million) are observed in Australia, Belgium, and Great Britain. A lot of data indicate a relationship between mesothelioma and asbestos. The hot areas for mesothelioma exactly correspond to the sites of industries with high asbestos use, such as shipbuilding and asbestos-cement industry. However, in many countries with high asbestos consumption, mesothelioma incidence is low. The reasons for this fact are not clear. The latency periods elapsing between first exposure to asbestos and development of mesothelioma are mostly longer than 40 yr. An inverse relationship exists between intensity of asbestos exposure and length of the latency period. Mesothelioma generally develops after long-time exposures to asbestos. Some recent studies show that the risk increases with the duration of exposure. Possible co-factors in the pathogenesis of asbestos-related mesothelioma include genetic predisposition, diets poor in fruit and vegetables, viruses, immune impairment, recurrent serosal inflammation. The study of co-morbidity in mesothelioma could give an insight into the pathogenesis of the tumor. While a levelling-off in mesothelioma incidence has been registered in some countries, a worsening of the epidemic is predictable in large parts of the world.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634686     DOI: 10.2486/indhealth.45.379

Source DB:  PubMed          Journal:  Ind Health        ISSN: 0019-8366            Impact factor:   2.179


  74 in total

1.  Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008.

Authors:  Vanya Delgermaa; Ken Takahashi; Eun-Kee Park; Giang Vinh Le; Toshiyuki Hara; Tom Sorahan
Journal:  Bull World Health Organ       Date:  2011-06-13       Impact factor: 9.408

Review 2.  The Role of Regulatory T Cells in Mesothelioma.

Authors:  Demelza J Ireland; Haydn T Kissick; Manfred W Beilharz
Journal:  Cancer Microenviron       Date:  2012-02-01

Review 3.  Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.

Authors:  Roberto E Favoni; Antonio Daga; Paolo Malatesta; Tullio Florio
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 4.  Radio-immunotherapy and chemo-immunotherapy as a novel treatment paradigm in malignant pleural mesothelioma.

Authors:  Licun Wu; Marc de Perrot
Journal:  Transl Lung Cancer Res       Date:  2017-06

5.  The impact of chemotherapy and its timing on survival in malignant peritoneal mesothelioma treated with complete debulking.

Authors:  Samer A Naffouje; Kiara A Tulla; George I Salti
Journal:  Med Oncol       Date:  2018-04-12       Impact factor: 3.064

6.  The relationship between malignant mesothelioma and an asbestos cement plant environmental risk: a spatial case-control study in the city of Bari (Italy).

Authors:  Marina Musti; Alessio Pollice; Domenica Cavone; Silvano Dragonieri; Massimo Bilancia
Journal:  Int Arch Occup Environ Health       Date:  2008-09-23       Impact factor: 3.015

Review 7.  Radical multimodality therapy for malignant pleural mesothelioma.

Authors:  Omar Abdel-Rahman; Zeinab Elsayed; Hadeer Mohamed; Mostafa Eltobgy
Journal:  Cochrane Database Syst Rev       Date:  2018-01-08

8.  Computerized segmentation and measurement of malignant pleural mesothelioma.

Authors:  William F Sensakovic; Samuel G Armato; Christopher Straus; Rachael Y Roberts; Philip Caligiuri; Adam Starkey; Hedy L Kindler
Journal:  Med Phys       Date:  2011-01       Impact factor: 4.071

9.  Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk?

Authors:  Marie-Claude F Jaurand; Annie Renier; Julien Daubriac
Journal:  Part Fibre Toxicol       Date:  2009-06-12       Impact factor: 9.400

10.  Susceptibility and resistance in the genesis of asbestos-related mesothelioma.

Authors:  Claudio Bianchi; Tommaso Bianchi
Journal:  Indian J Occup Environ Med       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.